Apyx Other Stockholder Equity from 2010 to 2024

APYX Stock  USD 1.69  0.24  16.55%   
Apyx Medical Other Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Other Stockholder Equity is likely to outpace its year average in 2024. During the period from 2010 to 2024, Apyx Medical Other Stockholder Equity regression line of annual values had r-squared of  0.94 and arithmetic mean of  52,590,747. View All Fundamentals
 
Other Stockholder Equity  
First Reported
1995-12-31
Previous Quarter
83.3 M
Current Value
84.3 M
Quarterly Volatility
20.3 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Apyx Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apyx Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 736.2 K, Interest Expense of 2.6 M or Selling General Administrative of 51.3 M, as well as many indicators such as Price To Sales Ratio of 1.65, Dividend Yield of 0.0 or PTB Ratio of 3.23. Apyx financial statements analysis is a perfect complement when working with Apyx Medical Valuation or Volatility modules.
  
Check out the analysis of Apyx Medical Correlation against competitors.
For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

Latest Apyx Medical's Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Apyx Medical over the last few years. It is Apyx Medical's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apyx Medical's overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Apyx Other Stockholder Equity Regression Statistics

Arithmetic Mean52,590,747
Geometric Mean47,607,447
Coefficient Of Variation39.13
Mean Deviation16,389,731
Median56,894,000
Standard Deviation20,577,206
Sample Variance423.4T
Range73.6M
R-Value0.97
Mean Square Error26.1T
R-Squared0.94
Slope4,467,334
Total Sum of Squares5927.9T

Apyx Other Stockholder Equity History

202485.2 M
202381.1 M
202273.3 M
202166.2 M
202061.1 M
201956.7 M
201858.6 M

About Apyx Medical Financial Statements

Apyx Medical investors use historical fundamental indicators, such as Apyx Medical's Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Apyx Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity81.1 M85.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.